54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 08
11:33 UTC
|
SEI
Solaris Energy Infrastructure
|
◎ Target | Sean Milligan ★☆☆☆☆ #3165 | Buy | $97.00→ $98.00+1.0% |
|
Aug 08
11:33 UTC
|
SBRY
J Sainsbury
|
◎ Target | firm only | Neutral | GBX 330→ GBX 346+4.8% |
|
Aug 08
11:33 UTC
|
SARO
StandardAero
|
◎ Target | Gavin Parsons ★★★☆☆ #1654 | Buy | $35.00→ $36.00+2.9% |
|
Aug 08
11:33 UTC
|
RYTM
Rhythm Pharmaceuticals
|
◎ Target | Priyanka Grover ★★☆☆☆ #2767 | Overweight | $145.00→ $146.00+0.7% |
|
Aug 08
11:33 UTC
|
RXO
RXO
|
◎ Target | Thomas Wadewitz ★★★☆☆ #1588 | Neutral | $26.00→ $23.00-11.5% |
|
Aug 08
11:33 UTC
|
RXO
RXO
|
◎ Target | Ariel Rosa ★★★☆☆ #1149 | Neutral | $30.00→ $23.00-23.3% |
|
Aug 08
11:33 UTC
|
RXO
RXO
|
◎ Target | Jason Seidl ★★★☆☆ #1472 | Sell | $19.00→ $17.50-7.9% |
|
Aug 08
11:33 UTC
|
RXO
RXO
|
◎ Target | Lucas Servera ★★★☆☆ #1347 | Buy | $30.00→ $28.00-6.7% |
|
Aug 08
11:33 UTC
|
RUN
Sunrun
|
◎ Target | Biju Perincheril not yet tracked | Positive | $18.00→ $15.00-16.7% |
|
Aug 08
11:33 UTC
|
RUN
Sunrun
|
◎ Target | Vikram Bagri ★☆☆☆☆ #2991 | Buy | $20.00→ $16.00-20.0% |
|
Aug 08
11:33 UTC
|
RSG
Republic Services
|
◎ Target | William Grippin ★★★☆☆ #2193 | Equal Weight | $233.00→ $240.00+3.0% |
|
Aug 08
11:33 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Chris Schott ★★★★★ #265 | Overweight | $58.00→ $62.00+6.9% |
|
Aug 08
11:33 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Douglas Tsao ★★★☆☆ #1548 | Buy | $34.00→ $41.00+20.6% |
|
Aug 08
11:33 UTC
|
ROIV
Roivant Sciences
|
◎ Target | Yatin Suneja ★☆☆☆☆ #2915 | Buy | $36.00→ $42.00+16.7% |
|
Aug 08
11:33 UTC
|
RMD
ResMed
|
◎ Target | Adam Maeder ★★★☆☆ #1398 | Neutral | $233.00→ $225.00-3.4% |
|
Aug 08
11:33 UTC
|
RMD
ResMed
|
◎ Target | Nathan Treybeck ★★★☆☆ #1268 | Equal Weight | $225.00→ $215.00-4.4% |
|
Aug 08
11:33 UTC
|
RMD
ResMed
|
◎ Target | Craig Wong-Pan ★★★★☆ #357 | Sec→ r Perform | $234.00→ $244.00+4.3% |
|
Aug 08
11:33 UTC
|
RMD
ResMed
|
◎ Target | Justin Patterson ★★★☆☆ #1704 | Overweight | $260.00→ $255.00-1.9% |
|
Aug 08
11:33 UTC
|
RLAY
Relay Therapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1059 | Overweight | $27.00→ $30.00+11.1% |
|
Aug 08
11:33 UTC
|
RL
Ralph Lauren
|
◎ Target | Paul Lejuez ★★★★☆ #882 | Buy | $400.00→ $455.00+13.8% |
|
Aug 08
11:33 UTC
|
RL
Ralph Lauren
|
◎ Target | Robert Drbul ★★★★☆ #726 | Buy | $450.00→ $460.00+2.2% |
|
Aug 08
11:33 UTC
|
RL
Ralph Lauren
|
◎ Target | Adrienne Yih ★★★☆☆ #1570 | Overweight | $439.00→ $463.00+5.5% |
|
Aug 08
11:33 UTC
|
RL
Ralph Lauren
|
◎ Target | Jay Sole ★★★☆☆ #1564 | Buy | $511.00→ $520.00+1.8% |
|
Aug 08
11:33 UTC
|
RL
Ralph Lauren
|
◎ Target | Dana Telsey ★★★☆☆ #1091 | Outperform | $460.00→ $470.00+2.2% |
|
Aug 08
11:33 UTC
|
RKT
Rocket Companies
|
◎ Target | Donald Fandetti ★★★☆☆ #1762 | Equal Weight | $17.00→ $15.00-11.8% |
|
Aug 08
11:33 UTC
|
RKT
Rocket Companies
|
◎ Target | Kyle Joseph ★★☆☆☆ #2565 | Overweight | $22.50→ $20.00-11.1% |
|
Aug 08
11:33 UTC
|
RKT
Rocket Companies
|
◎ Target | Daniel Kurnos ★☆☆☆☆ #3099 | Buy | $21.00→ $19.00-9.5% |
|
Aug 08
11:33 UTC
|
RKT
Rocket Companies
|
◎ Target | Richard Shane ★★★☆☆ #1087 | Neutral | $15.50→ $14.00-9.7% |
|
Aug 08
11:33 UTC
|
RKT
Rocket Companies
|
◎ Target | Daniel R. Perlin not yet tracked | Sec→ r Perform | $20.00→ $15.00-25.0% |
|
Aug 08
11:33 UTC
|
RGLD
Royal Gold
|
◎ Target | Daniel Major ★★☆☆☆ #2511 | Buy | $280.00→ $285.00+1.8% |
|
Aug 08
11:33 UTC
|
RGA
Reinsurance Group of America
|
◎ Target | Alex Scott ★★★★☆ #476 | Overweight | $278.00→ $290.00+4.3% |
|
Aug 08
11:33 UTC
|
REPL
Replimune Group
|
◎ Target | Anupam Rama ★★☆☆☆ #2755 | Overweight | $17.00→ $20.00+17.6% |
|
Aug 08
11:33 UTC
|
REI.UN
RioCan Real Estate Investment Trust
|
◎ Target | firm only | Outperform | C$24.00→ C$25.00+4.2% |
|
Aug 08
11:33 UTC
|
REAL
RealReal
|
◎ Target | Kunal Madhukar ★★★☆☆ #2135 | Neutral | $14.00→ $16.00+14.3% |
|
Aug 08
11:33 UTC
|
RCAT
Red Cat
|
◎ Target | Austin Bohlig ★☆☆☆☆ #3142 | Buy | $20.00→ $15.00-25.0% |
|
Aug 08
11:33 UTC
|
QSR
Restaurant Brands International
|
◎ Target | firm only | Sec→ r Perform | $83.00→ $81.00-2.4% |
|
Aug 08
11:33 UTC
|
QSR
Restaurant Brands International
|
◎ Target | Brian Mullan ★★☆☆☆ #2318 | Overweight | $85.00→ $81.00-4.7% |
|
Aug 08
11:33 UTC
|
QLT
Quilter
|
◎ Target | firm only | Buy | GBX 215→ GBX 220+2.3% |
|
Aug 08
11:33 UTC
|
QGEN
Qiagen
|
◎ Target | Casey Woodring ★★★★★ #9 | Overweight | $45.00→ $50.00+11.1% |
|
Aug 08
11:33 UTC
|
QBR.B
Quebecor
|
◎ Target | firm only | Outperform | C$69.00→ C$77.00+11.6% |
|
Aug 08
11:33 UTC
|
QBR.B
Quebecor
|
◎ Target | firm only | Sec→ r Perform | C$63.50→ C$66.00+3.9% |
|
Aug 08
11:33 UTC
|
QBR.B
Quebecor
|
◎ Target | firm only | Buy | C$72.00→ C$76.00+5.6% |
|
Aug 08
11:33 UTC
|
QBR.B
Quebecor
|
◎ Target | firm only | Sec→ r Perform | C$70.00→ C$71.00+1.4% |
|
Aug 08
11:33 UTC
|
QBR.B
Quebecor
|
◎ Target | firm only | Buy | C$78.00→ C$80.00+2.6% |
|
Aug 08
11:33 UTC
|
PZZA
Papa John's International
|
◎ Target | Dennis Geiger ★★★☆☆ #1489 | Neutral | $33.00→ $28.00-15.2% |
|
Aug 08
11:33 UTC
|
PZZA
Papa John's International
|
◎ Target | Brian Mullan ★★☆☆☆ #2318 | Neutral | $30.00→ $26.00-13.3% |
|
Aug 08
11:33 UTC
|
PUBM
PubMatic
|
◎ Target | Matthew Condon ★★☆☆☆ #2439 | Market Outperform | $12.00→ $20.00+66.7% |
|
Aug 08
11:33 UTC
|
PUBM
PubMatic
|
◎ Target | Barton Crockett ★★★★☆ #757 | Buy | $21.00→ $23.00+9.5% |
|
Aug 08
11:33 UTC
|
PRTH
Priority Technology
|
◎ Target | Vasundhara Govil ★★★☆☆ #1471 | Market Perform | $7.50→ $6.50-13.3% |
|
Aug 08
11:33 UTC
|
PRMB
Primo Brands
|
◎ Target | Nik Modi ★★★★☆ #509 | Outperform | $28.00→ $31.00+10.7% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.